NAI500

A bridge between

    • NAI500NAI500
      ·02-27 15:09

      Copper, the "Red Gold": Three Canadian Miners Leading the 2026 Resource Boom

      Industry experts dub copper "red gold" for its immense economic value. As the construction of AI data centers and related infrastructure accelerates, coupled with surging demand for large-scale upgrades to global power grids, a resource boom centered on this "red gold" is sweeping the global mining market in 2026. Amid this boom, three Canadian mining companies have become the market’s focus thanks to their strategic layouts and strong performance. $HudBay Minerals(HBM)$ and Capstone Copper (TSX:CS) have delivered substantial returns to investors over the past year, while Teck Resources (TSX:TECK.B) has also seen a notable share price surge since late 2025. The Cornerstone of Industrial Development In 2026, gold and silver prices have hit record hi
      86Comment
      Report
      Copper, the "Red Gold": Three Canadian Miners Leading the 2026 Resource Boom
    • NAI500NAI500
      ·02-27 15:06

      Moderna Rebounds: A Biotech Pioneer at a Critical Turning Point

      After years of lackluster performance, $Moderna, Inc.(MRNA)$ share price posted double-digit gains in January this year. The biotech firm, which rose to fame during the pandemic for its mRNA technology and the rapid development of a COVID-19 vaccine, has in recent years been hamstrung by two of its core pillars: the U.S. government terminated approximately $500 million in funding for mRNA vaccine development last year, while plummeting demand for its COVID-19 vaccine has left revenues a far cry from their peak levels. The company’s recent developments have been a mixed bag: its respiratory syncytial virus (RSV) vaccine was approved for commercial use in 2024, yet its cytomegalovirus (CMV) vaccine candidate failed in Phase III clinical trials just
      64Comment
      Report
      Moderna Rebounds: A Biotech Pioneer at a Critical Turning Point
    • NAI500NAI500
      ·02-27 14:59

      High Dividend Yields in the S&P 500: Treasures or Dividend Traps?

      Among $S&P 500(.SPX)$ components, stocks with the highest dividend yields always draw the most attention, especially from investors seeking stable cash flow. Yet a high dividend yield is not always a sign of a company’s sound operations; instead, it may result from a sustained drop in share price—a phenomenon known as a dividend trap. Currently, the top five dividend-yielding stocks in the S&P 500 all boast yields well above 6.4%, with LyondellBasell leading the pack at an astonishing 9.3%. But behind these tempting figures lie hidden risks. Are these stocks undervalued gems or ticking traps? This article breaks down each one in turn. What Is a Dividend Trap? Simply put, a dividend trap refers to a stock with an abnormally high dividend yi
      127Comment
      Report
      High Dividend Yields in the S&P 500: Treasures or Dividend Traps?
    • NAI500NAI500
      ·02-27 14:53

      Newmont: A Better Bet Than Gold Bullion in This Historic Gold Bull Market

      $Gold - main 2604(GCmain)$ When the price of gold surged past the all-time milestone of $5,000 an ounce with an annual gain of over 70%, the market’s attention became almost entirely fixated on this glittering safe-haven asset itself. Yet the real smart money may be shifting to the background—to the producers that turn underground ore into physical gold. In this historic gold bull market, Newmont (NEM), the world’s largest listed gold company, is proving with staggering financial results that it may offer more investment value than gold bullion itself. Gold prices have climbed more than 18% year to date, breaking above $5,000 an ounce—a figure not even the most optimistic gold bugs would have dared to imagine just two years ago. But while reta
      180Comment
      Report
      Newmont: A Better Bet Than Gold Bullion in This Historic Gold Bull Market
    • NAI500NAI500
      ·02-26 22:16

      Regeneron Pharmaceuticals: A Biotech Leader Poised for Long-Term Outperformance Despite Sector Under

      While the healthcare sector has underperformed the broader market in recent years, there are still plenty of stocks with long-term investment value within the industry. $Regeneron Pharmaceuticals(REGN)$ , a leading enterprise in the biotech space, is well-positioned to outperform the market over the next decade, backed by its core product strengths and a robust research and development (R&D) pipeline. Core Growth Driver Maintains Strong Momentum Dupixent currently stands as the company’s most critical product driving revenue growth. Co-developed with Sanofi, this drug has been approved for indications such as atopic dermatitis and holds a leading position in its therapeutic areas. In 2024, Dupixent achieved a major milestone with the approval
      110Comment
      Report
      Regeneron Pharmaceuticals: A Biotech Leader Poised for Long-Term Outperformance Despite Sector Under
    • NAI500NAI500
      ·02-26 22:12

      Hunting for Stocks Trading Far Below Analysts’ Average Target Prices

      Seeking out stocks trading well below analysts’ average target prices is often an effective way to uncover potential new additions to an investment portfolio. Investors should certainly not rush into buying based solely on this metric and need to conduct further in-depth research. Yet using it as a starting point for screening can help you quickly zero in on targets poised for substantial gains in the future. Wall Street is currently quite bullish on two stocks: $IONQ Inc.(IONQ)$ and $SoundHound AI Inc(SOUN)$ . Analysts covering IonQ have set an average target price of $74.89 for the stock, which is currently trading at around $33.30. This translates to a staggering potential upside of 125% based on the t
      328Comment
      Report
      Hunting for Stocks Trading Far Below Analysts’ Average Target Prices
    • NAI500NAI500
      ·02-26 21:45

      US Stocks: 10 S&P 500 Components with Over 20% YTD Drop Emerge as Analyst Buy Targets

      The US stock market has been trapped in a weak and volatile trend since 2026, with the S&P 500 Index posting a cumulative decline of 1% year to date as of Monday’s close. Beneath the surface of the overall market slump, however, a batch of deeply corrected stocks has quietly entered analysts’ buy radars. After a three-tier screening of 54 S&P 500 components that have fallen more than 20% this year, analysts identified 10 potential targets that combine valuation advantages, growth prospects and institutional consensus. Three hard screening criteria were set for this selection: Relative valuation advantage: Forward price-to-earnings (P/E) ratio, based on earnings estimates for the next 12 months, below the industry average; Superior growth potential: Expected 2-year compound annual g
      279Comment
      Report
      US Stocks: 10 S&P 500 Components with Over 20% YTD Drop Emerge as Analyst Buy Targets
    • NAI500NAI500
      ·02-26 21:27

      2026 Silver Market & Silver ETF Investment Guide

      The silver market staged a heart-stopping rollercoaster ride in 2026: amid extreme volatility, silver prices soared to an all-time high of $120 per ounce before plummeting sharply to the mid-$70 range. As a unique precious metal with both industrial and financial attributes, silver's performance is driven not only by industrial demand from sectors such as solar energy and electric vehicles but also by interest rates, inflation expectations and market sentiment. Compared with gold, silver's higher volatility makes it one of the most dynamic assets in the commodity market. Looking ahead to 2026-2030, persistent supply shortages and growing global demand are expected to drive a gradual climb in silver prices, potentially challenging the $145 mark. However, short-term fluctuations are inevitab
      3.21KComment
      Report
      2026 Silver Market & Silver ETF Investment Guide
    • NAI500NAI500
      ·02-26

      Scottie Reports Broad and High-Grade Gold at the Blueberry Contact Zone 14.4 g/t Gold over 40.75 Met

      Vancouver, British Columbia– Scottie Resources Corp.  $SCOTTIE RES CORP.(SCTSF)$ (FSE: SR80) (“Scottie” or the “Company“) is pleased to report final assays from its 2025 drilling of various zones within the Blueberry Contact Zone, at the Scottie Gold Mine Project (“Scottie Gold Mine” or the “Project”). The road-accessible Project is located 35 kilometres north of Stewart, BC, and is the subject of a newly released Preliminary Economic Assessment (“PEA”) entitled Scottie Gold Mine Project (Bird et al., October 28, 2025, Scottie Gold Mine Project, SEDAR+). In 2025, Scottie completed its biggest drill season ever, drilling more than 27,300 metres across 126 holes. This included 17 specialized holes (2,300 metres) focused on ground stabilit
      295Comment
      Report
      Scottie Reports Broad and High-Grade Gold at the Blueberry Contact Zone 14.4 g/t Gold over 40.75 Met
    • NAI500NAI500
      ·01-30

      💰Fees as Low as 0.08%! 7 Healthcare ETFs for 2026

      Hi, Tigers 🐯 Despite ongoing cost pressures, the healthcare sector’s growth outlook remains constructive. An ageing population and continued breakthroughs in medical innovation continue to provide long-term support Looking to invest in this sector but don’t wanna pick individual stocks? ETFs offer a simple and cost-efficient way to gain exposure! Of course, near-term challenges are real.According to a McKinsey report dated 12 January, the US healthcare system is under increasing financial pressure. Industry operating margins are expected to fall from 11.2% in 2019 to 8.9% in 2024, with payers and healthcare providers most affected. However, analysts expect conditions to improve gradually over the next three years.With an ageing population and steady demand for new therapies, healthcare rem
      991Comment
      Report
      💰Fees as Low as 0.08%! 7 Healthcare ETFs for 2026
     
     
     
     

    Most Discussed